Your browser doesn't support javascript.
loading
Antagonizing Integrin ß3 Increases Immunosuppression in Cancer.
Su, Xinming; Esser, Alison K; Amend, Sarah R; Xiang, Jingyu; Xu, Yalin; Ross, Michael H; Fox, Gregory C; Kobayashi, Takayuki; Steri, Veronica; Roomp, Kirsten; Fontana, Francesca; Hurchla, Michelle A; Knolhoff, Brett L; Meyer, Melissa A; Morgan, Elizabeth A; Tomasson, Julia C; Novack, Joshua S; Zou, Wei; Faccio, Roberta; Novack, Deborah V; Robinson, Stephen D; Teitelbaum, Steven L; DeNardo, David G; Schneider, Jochen G; Weilbaecher, Katherine N.
Afiliação
  • Su X; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Esser AK; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Amend SR; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Xiang J; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Xu Y; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Ross MH; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Fox GC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Kobayashi T; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Steri V; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • Roomp K; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg.
  • Fontana F; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Hurchla MA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Knolhoff BL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
  • Meyer MA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
  • Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Tomasson JC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Novack JS; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Zou W; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri. Deparment of Medicine, Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.
  • Faccio R; Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Novack DV; Deparment of Medicine, Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.
  • Robinson SD; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • Teitelbaum SL; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri. Deparment of Medicine, Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.
  • DeNardo DG; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
  • Schneider JG; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg. Department of Internal Medicine II, Saarland University Medical Center, Homburg/Saar, Germany.
  • Weilbaecher KN; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. KWEILBAE@DOM.wustl.edu.
Cancer Res ; 76(12): 3484-95, 2016 06 15.
Article em En | MEDLINE | ID: mdl-27216180
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Integrina beta3 / Tolerância Imunológica / Neoplasias Limite: Animals Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Integrina beta3 / Tolerância Imunológica / Neoplasias Limite: Animals Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article